Pelex, Inc.

Pelex is a digital health platform for pelvic floor disorders built on a proprietary connected medical device. The goal of the company is to revolutionize the patient experience by bringing diagnosis AND treatment of pelvic floor disorders out of the clinic and into the home.

Onasys Controls

Export control for shipping research and clinical materials is complex and fraught with human error. Onasys leverages industry best practice and regulations to ensure your organization is productive, compliant, and safe. Onasys was founded by industry experts at Weill Cornell Medicine and Fitzroy Health.

Soctera, Inc.

Soctera is developing the world’s first aluminum nitride-based power amplifier. These amplifiers will allow higher power operation than other material platforms, such as gallium nitride or silicon. Higher power translates to an increase in the distance a wireless signal can travel. This is of value in markets such as base stations and military radar systems. Soctera plans to expand from this initial product and develop the aluminum nitride platform as the future of high-frequency, high-power electronics.

Soctera spun out of an engineering lab at Cornell University in Ithaca, NY.

IpiNovyx Bio Inc.

IpiNovyx is a biopharmaceutical company that aims to transform the ways autoimmune and inflammatory are treated through a reversable, ultra-potent and non-toxic approach.

Convergent Therapeutics, Inc.

Convergent Therapeutics, Inc. is a clinical stage pharmaceutical company focused on developing next generation radiopharmaceutical therapies for prostate and other cancers. The company’s proprietary technology involves dual-targeted radionuclide therapy (RNT) developed by Dr. Neil Bander, Professor of Urologic Oncology at Weill Cornell Medicine and licensed to Convergent by Cornell University.

 

Sedec Therapeutics, Inc.

Sedec is a therapeutics company that aims to inhibit key factors in a subset of CD4+ T cells to decrease inflammation. This approach can be used to treat T cell-mediated autoimmune disorders, such as inflammatory bowel disease.

Kanvas Bioscience, Inc.

Kanvas Biosciences, Inc. has developed an approach to identify dense microbial organisms at a single-microbe resolution through spatially resolved metagenomics and a combination of multi-spectral imaging and innovative software. This technology circumvents metagenomic sequencing and can be applied as a diagnostic to identify microbial communities or study tumor-microbiome relationships.

Lo Bio Life Sciences LLC

Lo Bio has developed a rapid and low-cost approach to separate red blood cells from plasma using magnetic beads and a portable separator. This approach yields highly pure plasma from small volumes, takes less than two minutes, and can be applied for diagnostic tests for COVID-19, HIV 1 / 2, and HCV.